Adoptive T Cell Therapy for Solid Tumors: Pathway to Personalized Standard of Care

Adoptive cell therapy (ACT) with tumor-infiltrating T cells (TILs) has emerged as a promising therapy for the treatment of unresectable or metastatic solid tumors. One challenge to finding a universal anticancer treatment is the heterogeneity present between different tumors as a result of genetic i...

Descripción completa

Detalles Bibliográficos
Autores principales: Qin, Shuyang S., Melucci, Alexa D., Chacon, Alexander C., Prieto, Peter A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8067276/
https://www.ncbi.nlm.nih.gov/pubmed/33916369
http://dx.doi.org/10.3390/cells10040808

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8067276/
https://www.ncbi.nlm.nih.gov/pubmed/33916369
http://dx.doi.org/10.3390/cells10040808

Ejemplares similares